GISELA P

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 620387
                    [Title] => Molecular targets of cancer as basis for new drugs and immunotherapy
                    [Summary] => 
A few months ago, in this column I wrote about a close friend who has  survived AML (acute myeloid leukemia) for more than 10 years. It was in  an article on “Anticancer drugs from land and sea.” 
                    [DatePublished] => 2010-10-14 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1339989
                    [AuthorName] => Gisela Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 435181
                    [Title] => Are memories formed by prions?
                    [Summary] => 
In an article that appeared recently in Biosciences Hypotheses, we proposed that electrical activity at the synapse induces the surrounding prion molecules to aggregate.
                    [DatePublished] => 2009-01-29 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1296959
                    [AuthorName] => Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 433277
                    [Title] => Are memories formed by prions?
                    [Summary] => 
We still know very little about how our brain works. We don’t know how we think. We don’t know how we analyze and solve problems.
                    [DatePublished] => 2009-01-22 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1296959
                    [AuthorName] => Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 418498
                    [Title] => The future of RP science is bright
                    [Summary] => When one of us (EAP) started studying his major subject (Physics) in UP in the 50s, the department did not have a PhD in its faculty.
                    [DatePublished] => 2008-11-27 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1296959
                    [AuthorName] => Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 317408
                    [Title] => Battling tuberculosis on many levels
                    [Summary] => 
(Conclusion)
Treatment under DOTS consists of the daily administration of four drugs, namely, isoniazid, pyrazinamide, rifampin, and ethambutol, for two months; and a follow-up, thrice-a-week treatment of isoniazid and rifampin for another four months. The drugs affect different biochemical processes in the bacterium to inhibit its growth. Interestingly, some of these drugs enter the body in their inactive form.
                    [DatePublished] => 2006-01-19 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1754951
                    [AuthorName] => STAR SCIENCE By John Phillip L. Fadul
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Molecular targets of cancer as basis for new drugs and immunotherapy

By Gisela Padilla-Concepcion, PhD | October 14, 2010 - 12:00am

A few months ago, in this column I wrote about a close friend who has survived AML (acute myeloid leukemia) for more than 10 years. It was in an article on “Anticancer drugs from land and sea.”

Science and Environment

Are memories formed by prions?

By Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD | January 29, 2009 - 12:00am

In an article that appeared recently in Biosciences Hypotheses, we proposed that electrical activity at the synapse induces the surrounding prion molecules to aggregate.

Science and Environment

Are memories formed by prions?

By Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD | January 22, 2009 - 12:00am

We still know very little about how our brain works. We don’t know how we think. We don’t know how we analyze and solve problems.

Science and Environment

The future of RP science is bright

By Eduardo A. Padlan, PhD and Gisela P. Padilla-Concepcion, PhD | November 27, 2008 - 12:00am

When one of us (EAP) started studying his major subject (Physics) in UP in the 50s, the department did not have a PhD in its faculty.

Science and Environment

Battling tuberculosis on many levels

By STAR SCIENCE By John Phillip L. Fadul | January 19, 2006 - 12:00am

(Conclusion) Treatment under DOTS consists of the daily administration of four drugs, namely, isoniazid, pyrazinamide, rifampin, and ethambutol, for two months; and a follow-up, thrice-a-week treatment of isoniazid...

Science and Environment